Research shows that belimumab is working in lupus. Learn more and share your story during Thursday's #RheumJC Twitter chat. (Pictured here is IgG1 monoclonal antibody, the basis for belimumab. @molekuul.be/Shutterstock.com)
(ACR Pediatrics 2014) Children growing into young adults with rheumatic diseases often fail to get the care they need, for numerous complicated reasons. The ACA could change all this, with implications for adult rheumatologists. Here, a brief look at the situation and some solutions.
(ACR Pediatrics 2014) Large research partnerships are proving key to conquering childhood rheumatic diseases like juvenile idiopathic arthritis. To continue the advance, however, larger mergers and newer kinds of data are required.
(ACR Pediatrics 2014) New biologics have revolutionized care for children with juvenile arthritis in recent years. But a pediatric rheumatologist says this progress isn't nearly good enough, urging a much tougher agenda.
(ACR Pediatrics 2014) More links between the gut and arthritis: Children with spondyloarthritis have different enteric bacteria than healthy kids, adding to a growing body of evidence linking microbes to autoimmune disorders.
(ACR Pediatrics 2014) How will the hundreds of new genetic biomarkers being found in rheumatology help us to untangle the web of complex diseases? In a brief podcast, a specialist in both rheumatology and genetics discusses recent and future progress.
(ACR Pediatrics 2014) Pattern-sorting analysis similar to Google ad technology has identified clusters of disease measures in records of children with rheumatic disease that appear more useful than current criteria sets.